Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 37Carcinoma, Hepatocellular 14Ovarian Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Stomach Neoplasms 3Rectal Neoplasms 3Neoplasm Metastasis 3Glioblastoma 3Recurrence 2Liver Neoplasms 2Diabetes Mellitus, Insulin-Dependent, 12 2Brain Neoplasms 2mCRC 1Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Spinocerebellar Degenerations 1Small Cell Lung Carcinoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms Malignant 1Proteinuria 1Platinum-sensitive Relapsed Ovarian Cancer 1Platinum-resistant Recurrent Ovarian Cancer (PROC) 1Platinum-resistant Recurrent Ovarian Cancer 1Osteosarcoma 1Non-small Cell Lung Cancer Patients with Brain Metastases 1Neutropenia 1Neoplastic Cells, Circulating 1NSCLC 1Metastatic Colorectal Cancer With Left-sided Primary Tumor 1Medulloblastoma 1

Interventions

trifluridine tipiracil drug combination 1Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Meropenem 1Levofloxacin 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Bevacizumab 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neutropenia × Bevacizumab × Clear all
NCT07071844 2025-07-17

BETWEEN

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
162 enrolled
Gastrointestinal

Neutropenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡